ORREPASTE

Krajina: Malajzia

Jazyk: angličtina

Zdroj: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Aktívna zložka:

TRIAMCINOLONE ACETONIDE

Dostupné z:

HOE PHARMACEUTICALS SDN. BHD.

INN (Medzinárodný Name):

TRIAMCINOLONE ACETONIDE

Počet v balení:

5gm mcg/mL

Výrobca:

HOE PHARMACEUTICALS SDN. BHD.

Príbalový leták

_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP) _
_ _
ORREPASTE
Triamcinolone Acetonide (0.1%w/w)
1
WHAT IS IN THIS LEAFLET
1.
What Orrepaste is used for
2.
How Orrepaste works
3.
Before you use Orrepaste
4.
How to use Orrepaste
5.
While you are using
Orrepaste
6.
Side effects
7.
Storage and Disposal of
Orrepaste
8.
Product description
9.
Manufacturer and Product
Registration Holder
10.
Date of revision
This leaflet answers some common
questions about Orrepaste. It does
not contain all the available
information. It does not take the
place of talking to your pharmacist
or doctor.
All medicines have risks and
benefits. Your pharmacist or
doctor has weighed the risks of
you taking Orrepaste against the
benefits they expect it will have
for you.
Keep this leaflet with the medicine.
You may need to read it again.
WHAT ORREPASTE IS USED FOR
Orrepaste is an oral paste used as
adjunctive treatment and for
temporary relief of symptoms
associated with oral inflammatory
lesions and ulcerative lesions
resulting from trauma.
HOW ORREPASTE WORKS
Orrepaste contains triamcinolone,
a corticosteroid.
Triamcinolone reduces the actions
of chemicals in the body that cause
inflammation, redness, and
swelling.
Ask your pharmacist or doctor if
you have any questions about this
medicine.
BEFORE YOU USE ORREPASTE
_-When you must not use it_
Allergic (hypersensitive) to
Triamcinolone Acetonide and
Propylene Glycol or any of the
ingredients listed at the end of this
leaflet.
If you have tuberculosis (bacterial
infection that mainly affects the
lung), ulcer in digestive tract,
diabetes, fungal, viral or bacterial
infections of the mouth or throat.
If the packaging shows signs of
tampering.
If the expiry date (EXP) printed on
the pack has passed.
_-Before you start to use it_
Ask your doctor or pharmacist for
advice before taking this medicine
if you are pregnant or breast-
feeding.
_-Taking other medicines_
Inform your pharmacist or doctor
if you are taking any other
products (such as medicines
purchased without a doctor's
prescription, pre

Súhrn charakteristických

Est. 1979
ORREPASTE
NAME AND STRENGTH OF ACTIVE SUBSTANCE : Triamcinolone Acetonide 0.1%
w/w.
PRODUCT DESCRIPTION : A light green paste with mint flavour and odour.
Other ingredients are Briliant Blue, Quinoline Yellow, Propylparaben,
Methylparaben,
Peppermint Oil, Sodium Polyacrylate, Pectin, Propylene Glycol,
Sorbitol 70% Solution, Sodium
Carboxymethylcellulose and Purified Water.
PHARMACODYNAMICS
:
Triamcinolone
Acetonide
is
a
synthetic
corticosteroid
which
possesses anti-inflammatory, antipruritic and anti-allergic action.
The emollient dental paste acts
as an adhesive vehicle for applying the active medication to the oral
tissues. The vehicle
provides a protective covering which may serve to temporarily reduce
the pain associated with
oral irritation.
PHARMACOKINETICS : When administered topically, particularly under
occlusive dressings or
when the skin is broken, sufficient corticosteroid may be absorbed to
give systemic effects.
Corticosteroids are extensively bound to plasma proteins. Only unbound
corticosteroid has
pharmacological effects or is metabolized. They are metabolized mainly
in the liver, also in the
kidney, and are excreted in the urine.
INDICATIONS : Adjunctive treatment and for temporary relief of
symptoms associated with oral
inflammatory lesions and ulcerative lesions resulting from trauma.
CONTRAINDICATIONS : This preparation is contraindicated in patients
with a history of
hypersensitivity to any of its components and propylene glycol.
Because it contains a corticoster-
oid, the preparation is contraindicated in the presence of fungal,
viral or bacterial infections of the
mouth or throat.
DRUG INTERACTION : Not known.
ADVERSE EFFECT : Prolonged administration may elicit the adverse
reactions known to occur
with systemic steroid preparations; for example, adrenal suppression,
alteration of glucose
metabolism, protein catabolism, peptic ulcer activation, and others.
These are usually reversible
and disappear when the hormone is discontinued. Systemic adverse
reactions, such as vision
blurr